Clifford E. Berkman
Affiliations: | Chemistry | Washington State University, Pullman, WA, United States |
Area:
Biochemistry, OncologyGoogle:
"Clifford Berkman"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mesbahi N, Yoon H, Fulton MD, et al. (2025) A small-molecule pretargeting approach for PSMA-targeted conjugates. Bioorganic & Medicinal Chemistry Letters. 122: 130213 |
| Rani A, Pulukuri AJ, Wei J, et al. (2024) PSMA-Targeted 2-Deoxyglucose-Based Dendrimer Nanomedicine for the Treatment of Prostate Cancer. Biomacromolecules |
| Yoon H, Savoy EA, Mesbahi N, et al. (2024) A PSMA-targeted doxorubicin small-molecule drug conjugate. Bioorganic & Medicinal Chemistry Letters. 129712 |
| Dhull A, Wei J, Pulukuri AJ, et al. (2024) PSMA-targeted dendrimer as an efficient anticancer drug delivery vehicle for prostate cancer. Nanoscale |
| Savoy EA, Olatunji FP, Fulton MD, et al. (2023) PSMA-targeted small-molecule drug-conjugates with valine-citrulline and phosphoramidate cleavable linkers. Bioorganic & Medicinal Chemistry Letters. 129573 |
| Olatunji FP, Pun M, Herman JW, et al. (2022) Modular Smart Molecules for PSMA-Targeted Chemotherapy. Molecular Cancer Therapeutics |
| Talley TT, Chao CK, Berkman CE, et al. (2020) Inhibition of acetylcholinesterases by stereoisomeric organophosphorus compounds containing both thioester and p-nitrophenyl leaving groups. Chemical Research in Toxicology |
| Ling X, Latoche JD, Choy CJ, et al. (2019) Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging |
| White DS, Choy CJ, Moural TW, et al. (2019) Bis(benzoyl) phosphate inactivators of beta-lactamase C from Mtb. Bioorganic & Medicinal Chemistry Letters |
| Behr SC, Aggarwal R, Van Brocklin HF, et al. (2018) First-in-Human Phase I study of CTT1057, a Novel F Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate Specific Membrane Antigen in Prostate Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |